Location History:
- Melsungen, DE (2016 - 2020)
- Wurmlingen, DE (2022)
Company Filing History:
Years Active: 2016-2022
Title: Innovations in Extracorporeal Blood Treatment by Jennifer Steger
Introduction
Jennifer Steger is a notable inventor based in Melsungen, Germany. She has made significant contributions to the field of medical technology, particularly in the area of extracorporeal blood treatment. With a total of 4 patents to her name, her work focuses on improving the efficiency and safety of dialysis machines.
Latest Patents
One of her latest patents is a "Monitoring device and method for monitoring an extracorporeal blood treatment device." This invention includes a system for monitoring a dialysis machine, which features an extracorporeal blood circuit. The device is designed to select and sense a measured value during operation, allowing for the comparison of actual performance against a stored target course. If deviations exceed a defined tolerance, the system can identify potential defects.
Another significant patent is for a "Device for extracorporeal blood treatment with gravimetric balancing and possibility of ultrafiltration." This invention includes an internal fluidic system that connects to a blood treatment unit, such as a dialyzer. It features balancing chambers for both fresh and used treatment fluids, equipped with measuring devices for gravimetric detection. This innovation aims to enhance the accuracy of fluid management in dialysis procedures.
Career Highlights
Jennifer Steger is currently employed at B. Braun Avitum AG, a company renowned for its advancements in medical technology. Her work at the company has allowed her to focus on developing innovative solutions that address critical challenges in blood treatment.
Collaborations
Throughout her career, Jennifer has collaborated with esteemed colleagues, including Christof Strohhoefer and Jens Schreiber. These partnerships have contributed to the successful development of her patented technologies.
Conclusion
Jennifer Steger's contributions to the field of extracorporeal blood treatment exemplify her commitment to innovation and patient care. Her patents reflect a deep understanding of medical technology and a dedication to improving treatment outcomes for patients undergoing dialysis.